Dr. Tammo Boinowitz takes over the responsibility as Head of Evonik’s Personal Care business line, effective January 1, 2015. He is succeeding Dr. Dietmar Moll, who will move into a new role and take care of strategic projects in the future. Dr. Boinowitz was appointed to the position after successfully leading the Comfort & Insulation business line for three years.
Dr. Boinowitz, who holds a PhD in chemistry, joined the former Goldschmidt AG in 1995. After holding a number of positions in Research & Development and Application Technology, he worked as Global Technical Director of today's Comfort & Insulation business line from 2003 to 2006 and was assigned as Business Director APAC to the business line's Asia-Pacific business from 2006 to 2008, working from Shanghai.
After leading strategic growth projects for the Consumer Specialties business unit and working for the Evonik Corporate Development Division, he was appointed Head of the Comfort & Insulation business line in December 2011.
Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.
Evonik is active in over 100 countries around the world. In fiscal 2013 more than 33,500 employees generated sales of around €12.7 billion and an operating profit (adjusted EBITDA) of about €2.0 billion.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.